ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,213,000 | +40.6% | 30,000 | +100.0% | 0.05% | +58.8% |
| Q2 2015 | $863,000 | +171.4% | 15,000 | +200.0% | 0.03% | +142.9% |
| Q1 2015 | $318,000 | +2.9% | 5,000 | 0.0% | 0.01% | +27.3% |
| Q4 2014 | $309,000 | -20.4% | 5,000 | -50.0% | 0.01% | +22.2% |
| Q3 2014 | $388,000 | -40.1% | 10,000 | -46.8% | 0.01% | -35.7% |
| Q2 2014 | $648,000 | +70.5% | 18,800 | +113.6% | 0.01% | +75.0% |
| Q1 2014 | $380,000 | -52.8% | 8,800 | -56.5% | 0.01% | -55.6% |
| Q4 2013 | $805,000 | +7.3% | 20,210 | +1.0% | 0.02% | +125.0% |
| Q3 2013 | $750,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |